NSE:INDRAMEDCO Statistics

Total Valuation

NSE:INDRAMEDCO has a market cap or net worth of INR 39.62 billion. The enterprise value is 36.73 billion.

Market Cap	39.62B
Enterprise Value	36.73B

Important Dates

The last earnings date was Wednesday, May 21, 2025.

Earnings Date	May 21, 2025
Ex-Dividend Date	Sep 13, 2024

Share Statistics

NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has increased by 0.01% in one year.

Current Share Class	91.67M
Shares Outstanding	91.67M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	2.90%
Owned by Institutions (%)	7.33%
Float	40.99M

Valuation Ratios

The trailing PE ratio is 24.61 and the forward PE ratio is 20.22.

PE Ratio	24.61
Forward PE	20.22
PS Ratio	2.92
PB Ratio	6.64
P/TBV Ratio	6.65
P/FCF Ratio	32.90
P/OCF Ratio	25.27
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.04, with an EV/FCF ratio of 30.50.

EV / Earnings	22.81
EV / Sales	2.71
EV / EBITDA	15.04
EV / EBIT	18.37
EV / FCF	30.50

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.05.

Current Ratio	2.41
Quick Ratio	2.23
Debt / Equity	0.05
Debt / EBITDA	0.13
Debt / FCF	0.27
Interest Coverage	31.89

Financial Efficiency

Return on equity (ROE) is 29.97% and return on invested capital (ROIC) is 21.90%.

Return on Equity (ROE)	29.97%
Return on Assets (ROA)	15.87%
Return on Invested Capital (ROIC)	21.90%
Return on Capital Employed (ROCE)	29.71%
Revenue Per Employee	4.56M
Profits Per Employee	540,779
Employee Count	2,977
Asset Turnover	1.72
Inventory Turnover	118.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.39% in the last 52 weeks. The beta is 0.58, so NSE:INDRAMEDCO's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+75.39%
50-Day Moving Average	407.82
200-Day Moving Average	428.67
Relative Strength Index (RSI)	55.35
Average Volume (20 Days)	210,604

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:INDRAMEDCO had revenue of INR 13.56 billion and earned 1.61 billion in profits. Earnings per share was 17.56.

Revenue	13.56B
Gross Profit	4.94B
Operating Income	2.00B
Pretax Income	2.16B
Net Income	1.61B
EBITDA	2.44B
EBIT	2.00B
Earnings Per Share (EPS)	17.56

Full Income Statement

Balance Sheet

The company has 3.22 billion in cash and 327.60 million in debt, giving a net cash position of 2.89 billion or 31.52 per share.

Cash & Cash Equivalents	3.22B
Total Debt	327.60M
Net Cash	2.89B
Net Cash Per Share	31.52
Equity (Book Value)	5.97B
Book Value Per Share	65.04
Working Capital	2.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.57 billion and capital expenditures -363.30 million, giving a free cash flow of 1.20 billion.

Operating Cash Flow	1.57B
Capital Expenditures	-363.30M
Free Cash Flow	1.20B
FCF Per Share	13.14

Full Cash Flow Statement

Margins

Gross margin is 36.39%, with operating and profit margins of 14.74% and 11.87%.

Gross Margin	36.39%
Operating Margin	14.74%
Pretax Margin	15.95%
Profit Margin	11.87%
EBITDA Margin	18.01%
EBIT Margin	14.74%
FCF Margin	8.88%

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 1.02%.

Dividend Per Share	4.50
Dividend Yield	1.02%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	4
Payout Ratio	25.30%
Buyback Yield	-0.01%
Shareholder Yield	1.01%
Earnings Yield	4.06%
FCF Yield	3.04%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a